[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Hepatitis C Market Size, Trends, Analysis, and Outlook By Diagnosis (Liver Biopsy, Blood Tests), By Treatment (Antiviral Drugs, Immune Modulator Drugs, Others), By End-User (Hospitals and Clinics, Diagnostic Laboratory, Others), by Country, Segment, and Companies, 2024-2032

April 2024 | 205 pages | ID: H8AAF019594AEN
VPAResearch

US$ 3,980.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Hepatitis C market size is poised to register 12.8% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Hepatitis C market across By Diagnosis (Liver Biopsy, Blood Tests), By Treatment (Antiviral Drugs, Immune Modulator Drugs, Others), By End-User (Hospitals and Clinics, Diagnostic Laboratory, Others)

The Hepatitis C market is experiencing significant transformation driven by advancements in antiviral therapies, screening initiatives, and public health interventions aimed at eliminating the hepatitis C virus (HCV) as a global health threat. Hepatitis C, a viral infection affecting the liver, poses significant challenges in disease management and transmission prevention. The market is driven by the development of direct-acting antiviral drugs (DAAs) that offer high cure rates, shorter treatment durations, and improved tolerability compared to traditional interferon-based regimens. Further, the implementation of screening programs, access to affordable treatment options, and harm reduction strategies are driving progress towards the World Health Organization's goal of eliminating HCV as a public health threat by 2030. By leveraging innovative treatment approaches, such as pan-genotypic therapies and decentralized care delivery models, the market is poised for further expansion as stakeholders work towards achieving universal access to HCV testing, treatment, and prevention services.

Hepatitis C Market Drivers, Trends, Opportunities, and Growth Opportunities

This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Hepatitis C market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Hepatitis C survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Hepatitis C industry.

Key market trends defining the global Hepatitis C demand in 2024 and Beyond

The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.

Hepatitis C Market Segmentation- Industry Share, Market Size, and Outlook to 2032

The Hepatitis C industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Hepatitis C companies scaling up production in these sub-segments with a focus on expanding into emerging countries.

Key strategies adopted by companies within the Hepatitis C industry

Leading Hepatitis C companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Hepatitis C companies.

Hepatitis C Market Study- Strategic Analysis Review

The Hepatitis C market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
  • Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
  • Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
  • Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
  • Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
Hepatitis C Market Size Outlook- Historic and Forecast Revenue in Three Cases

The Hepatitis C industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.

Hepatitis C Country Analysis and Revenue Outlook to 2032

The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.

North America Hepatitis C Market Size Outlook- Companies plan for focused investments in a changing environment

The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Hepatitis C market segments. Similarly, Strong market demand is encouraging Canadian Hepatitis C companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Hepatitis C market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.

Europe Hepatitis C Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities

The German industry remains the major market for companies in the European Hepatitis C industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Hepatitis C market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.

Asia Pacific Hepatitis C Market Size Outlook- an attractive hub for opportunities for both local and global companies

The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Hepatitis C in Asia Pacific. In particular, China, India, and South East Asian Hepatitis C markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.

Latin America Hepatitis C Market Size Outlook- Continued urbanization and rising income levels

Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.

Middle East and Africa Hepatitis C Market Size Outlook- continues its upward trajectory across segments

Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Hepatitis C market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Hepatitis C.

Hepatitis C Market Company Profiles

The global Hepatitis C market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are AbbVie Inc, Astellas Pharma Inc, Bristol-Myers Squibb Company, Cipla Inc, Daiichi Sankyo Company Ltd, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Gilead Sciences Inc, GlaxoSmithKline plc, Johnson & Johnson, Merck & Co. Inc, Novartis AG, Takeda Pharmaceutical Company Ltd.

Recent Hepatitis C Market Developments

The global Hepatitis C market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.

Hepatitis C Market Report Scope

Parameters: Revenue, Volume Price

Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)

Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)

Qualitative Analysis
  • Pricing Analysis
  • Value Chain Analysis
  • SWOT Profile
  • Market Dynamics- Trends, Drivers, Challenges
  • Porter’s Five Forces Analysis
  • Macroeconomic Impact Analysis
  • Case Scenarios- Low, Base, High
Market Segmentation:

By Diagnosis

Liver Biopsy

Blood Tests

By Treatment

Antiviral Drugs

Immune Modulator Drugs

Others

By End-User

Hospitals and Clinics

Diagnostic Laboratory

Others

Geographical Segmentation:
  • North America (3 markets)
  • Europe (6 markets)
  • Asia Pacific (6 markets)
  • Latin America (3 markets)
  • Middle East Africa (5 markets)
Companies

AbbVie Inc

Astellas Pharma Inc

Bristol-Myers Squibb Company

Cipla Inc

Daiichi Sankyo Company Ltd

Eli Lilly and Company

F. Hoffmann-La Roche Ltd

Gilead Sciences Inc

GlaxoSmithKline plc

Johnson & Johnson

Merck & Co. Inc

Novartis AG

Takeda Pharmaceutical Company Ltd

Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY

1.1 Hepatitis C Market Overview and Key Findings, 2024
1.2 Hepatitis C Market Size and Growth Outlook, 2021- 2030
1.3 Hepatitis C Market Growth Opportunities to 2030
1.4 Key Hepatitis C Market Trends and Challenges
  1.4.1 Hepatitis C Market Drivers and Trends
  1.4.2 Hepatitis C Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Hepatitis C Companies

2. HEPATITIS C MARKET SIZE OUTLOOK TO 2030

2.1 Hepatitis C Market Size Outlook, USD Million, 2021- 2030
2.2 Hepatitis C Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024

3. HEPATITIS C MARKET- STRATEGIC ANALYSIS REVIEW

3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis

4. HEPATITIS C MARKET SEGMENTATION ANALYSIS AND OUTLOOK

4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Diagnosis
Liver Biopsy
Blood Tests
By Treatment
Antiviral Drugs
Immune Modulator Drugs
Others
By End-User
Hospitals and Clinics
Diagnostic Laboratory
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030

5. REGION-WISE MARKET OUTLOOK TO 2030

5.1 Key Findings for Asia Pacific Hepatitis C Market, 2025
5.2 Asia Pacific Hepatitis C Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Hepatitis C Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Hepatitis C Market, 2025
5.5 Europe Hepatitis C Market Size Outlook by Type, 2021- 2030
5.6 Europe Hepatitis C Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Hepatitis C Market, 2025
5.8 North America Hepatitis C Market Size Outlook by Type, 2021- 2030
5.9 North America Hepatitis C Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Hepatitis C Market, 2025
5.11 South America Pacific Hepatitis C Market Size Outlook by Type, 2021- 2030
5.12 South America Hepatitis C Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Hepatitis C Market, 2025
5.14 Middle East Africa Hepatitis C Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Hepatitis C Market Size Outlook by Application, 2021- 2030

6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030

6.1 US Hepatitis C Market Size Outlook and Revenue Growth Forecasts
6.2 US Hepatitis C Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Hepatitis C Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Hepatitis C Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Hepatitis C Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Hepatitis C Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Hepatitis C Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Hepatitis C Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Hepatitis C Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Hepatitis C Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Hepatitis C Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Hepatitis C Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Hepatitis C Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Hepatitis C Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Hepatitis C Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Hepatitis C Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Hepatitis C Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Hepatitis C Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Hepatitis C Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Hepatitis C Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Hepatitis C Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Hepatitis C Industry Drivers and Opportunities

7. HEPATITIS C MARKET OUTLOOK ACROSS SCENARIOS

7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case

8. HEPATITIS C COMPANY PROFILES

8.1 Profiles of Leading Hepatitis C Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
AbbVie Inc
Astellas Pharma Inc
Bristol-Myers Squibb Company
Cipla Inc
Daiichi Sankyo Company Ltd
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
Gilead Sciences Inc
GlaxoSmithKline plc
Johnson & Johnson
Merck & Co. Inc
Novartis AG
Takeda Pharmaceutical Company Ltd.

9. APPENDIX

9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information


More Publications